2231 GMT [Dow Jones]--In healthcare, drug wholesalers and pathology specialists are most exposed to higher fuel prices stoked by the conflict in the Middle East. That's the view of Ord Minnett, which trims price targets on several stocks in Australia's healthcare sector, including Ebos, Paragon Care and Australian Clinical Labs. "We note that these businesses have freight and logistics operations (e.g. medicine supply, sample transportation) and a limited ability to pass on input costs near-term," analyst Tom Godfrey says. "As an example, Ebos is run-rating A$182 million of freight costs in FY26 (1% of revenue, 16% of opex)." Its price target on Ebos falls 3.3% to A$29.00/share. Ord Minnett cuts price targets on Paragon Care and Australian Clinical Labs by 5.7% and 8.3% to A$0.33/share and A$2.20/share, respectively. (david.winning@wsj.com; @dwinningWSJ)

(END) Dow Jones Newswires

March 23, 2026 18:37 ET (22:37 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.